Zobrazeno 1 - 10
of 41
pro vyhledávání: ''
Autor:
Jan-Stefan van der Walt, Joji Mori, Takahiro Nakayama, Kenichi Inoue, Yoshinori Ito, George W. Sledge, Yasuo Miyoshi, Tsutomu Kawaguchi, Masato Takahashi, Yoshinori Tanizawa, Masakazu Toi, Antonio Llombart-Cussac, Norikazu Masuda, Hiroji Iwata, Hirofumi Mukai, Sachi Sakaguchi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This was a Japanese subpopulation analysis of MONARCH 2, a double-blind, randomized, placebo-controlled, phase 3 study of abemaciclib plus fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-neg
Autor:
Ring, A., Battisti, N.M.L., Reed, M.W.R., Herbert, E., Morgan, J.L., Bradburn, M., Walters, S.J., Collins, K.A., Ward, S.E., Holmes, G.R., Burton, Maria, Lifford, K., Edwards, A., Robinson, T.G., Martin, C., Chater, T., Pemberton, K.J., Brennan, A., Cheung, K.L., Todd, A., Audisio, R.A., Wright, J., Simcock, R., Green, T., Revell, D., Gath, J., Horgan, K., Holcombe, C., Winter, M.C., Naik, J., Parmeshwar, R., Gosney, M.A., Hatton, M.Q., Thompson, A.M., Wyld, L., Collins, K., Ward, S., Holmes, G., Morgan, J., Walters, S., Burton, M., Brain, K., Robinson, T., Pemberton, K., Shrestha, A., Nettleship, A., Richards, P., Harder, H., Audisio, R., Murray, C., Thomson, A.M., Gosney, M., Hatton, M., Armitage, F., Patnick, J., Revill, D., Winter, M.
Publikováno v:
British Journal of Cancer
Background Chemotherapy improves outcomes for high risk early breast cancer (EBC) patients but is infrequently offered to older individuals. This study determined if there are fit older patients with high-risk disease who may benefit from chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed056944ecd27827ab3bd963813fe40
http://sro.sussex.ac.uk/id/eprint/101218/1/s41416-021-01388-9.pdf
http://sro.sussex.ac.uk/id/eprint/101218/1/s41416-021-01388-9.pdf
Autor:
Agneta Wennman-Larsen, Linnea Kjeldgård, Marie I. Nilsson, Kristina Alexanderson, Lena-Marie Petersson, Kerstin S. Fugl-Meyer, Mariann Olsson
Publikováno v:
Quality of Life Research
PURPOSE: To explore, among women of working age, satisfaction with life as a whole and with different life domains, and its associations with social and health variables, shortly after breast cancer surgery. METHODS: This cross-sectional study includ
Publikováno v:
Journal of cancer survivorship : research and practice, vol 4, iss 3
Melisko, Michelle E.; Goldman, Mindy; & Rugo, Hope S.(2010). Amelioration of sexual adverse effects in the early breast cancer patient. Journal of Cancer Survivorship: Research and Practice, 4(3), pp 247-255. doi: 10.1007/s11764-010-0130-1. Retrieved from: http://www.escholarship.org/uc/item/3905k9c0
Journal of Cancer Survivorship
Melisko, Michelle E.; Goldman, Mindy; & Rugo, Hope S.(2010). Amelioration of sexual adverse effects in the early breast cancer patient. Journal of Cancer Survivorship: Research and Practice, 4(3), pp 247-255. doi: 10.1007/s11764-010-0130-1. Retrieved from: http://www.escholarship.org/uc/item/3905k9c0
Journal of Cancer Survivorship
Background As the number of breast cancer survivors increases, the long term consequences of breast cancer treatment are gaining attention. Sexual dysfunction is a common complaint amongst breast cancer survivors, and there are few evidence based rec
Publikováno v:
Quality of Life Research
Purpose Most breast cancer patients receive psychosocial support interventions. However, the effectiveness of these interventions has not yet been clarified. Quality of life (QOL) was an important construct that should be considered when assessing th
Autor:
Bilge Pakiz, Cheryl L. Rock, Jeanne F. Nichols, Deborah L. Taylor, Shirley W. Flatt, Wayne A. Bardwell
Publikováno v:
Taylor, Deborah L.; Nichols, Jeanne F.; Pakiz, Bilgé; Bardwell, Wayne A.; Flatt, Shirley W.; & Rock, Cheryl L.(2010). Relationships Between Cardiorespiratory Fitness, Physical Activity, and Psychosocial Variables in Overweight and Obese Breast Cancer Survivors. International Journal of Behavioral Medicine: Official Journal of the International Society of Behavioral Medicine, 17(4), pp 264-270. doi: 10.1007/s12529-010-9076-y. Retrieved from: http://www.escholarship.org/uc/item/6c8526pp
International Journal of Behavioral Medicine
International Journal of Behavioral Medicine
Background Breast cancer survivors not only experience distressing physical symptoms associated with treatments, but also are faced with psychosocial challenges. Despite growing scientific evidence that physical activity (PA) may mitigate psychosocia
Autor:
Tarek Sahmoud, Yutaka Tokuda, Yoshiaki Rai, Hirotaka Iwase, Shozo Ohsumi, Hirofumi Mukai, Ashok Panneerselvam, Woo Chul Noh, Yoshinori Ito, Puttisak Puttawibul, Hideo Inaji, Tetiana Taran, Vichien Srimuninnimit, Hiroji Iwata, Norikazu Masuda, Takahiro Nakayama, Mona El-Hashimy, Shinzaburo Noguchi, Jun Horiguchi, Shinji Ohno, Katsumasa Kuroi, Byeong Woo Park
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background The addition of mTOR inhibitor everolimus (EVE) to exemestane (EXE) was evaluated in an international, phase 3 study (BOLERO-2) in patients with hormone-receptor-positive (HR+) breast cancer refractory to letrozole or anastrozole. The safe
Autor:
Mikołaj Majkowicz, Justyna Gołębiewska, Bolesław Rutkowski, Justyna Janiszewska, Monika Lichodziejewska-Niemierko
Publikováno v:
International Urology and Nephrology
Objective Anxiety is the most frequent emotional reaction to the chronic somatic disease. However, little is known about anxiety and coping strategies in patients with end-stage renal disease (ESRD) undergoing renal replacement therapies (RRTs). The
Autor:
Paul E. Goss
Publikováno v:
Breast Cancer Research and Treatment
Relapse after completing adjuvant tamoxifen therapy is a persistent threat for women with hormone-responsive breast cancer. Third-generation aromatase inhibitors, such as letrozole, provide a new option for extended adjuvant hormonal therapy after 5
Autor:
Iris Bartula, Kerry A. Sherman
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer patients are at increased risk of sexual dysfunction. Despite this, both patients and practitioners are reluctant to initiate a conversation about sexuality. A sexual dysfunction screening tool would be helpful in clinical practice and